Acute Lymphoblastic Leukemia Refractory
4 clinical trials · Condition
◉ Watch Acute Lymphoblastic Leukemia Refractory
| Record | Firm | Date |
|---|---|---|
| Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia (NCT03573700) | St. Jude Children's Research Hospital | 2018-07-24 |
Track Acute Lymphoblastic Leukemia Refractory automatically
Every clearance here is in the API, with alerts when new ones post.